In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

Returning from the 2025 American Academy of Ophthalmology Annual Meeting in Orlando, Dr Garg discusses the role of patient monitoring, GLP-1 inhibitors, and cutting-edge approaches to maintaining eye ...

We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Back ...

Population-based studies have shown retinal disorders are the most common cause of irreversible blindness in developed countries and the second most common cause of blindness after cataracts in ...

Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as a beacon of hope for millions affected by these ...

In a study published in the journal ACS Nano and supported by the National Institutes of Health, the research team showed that nanoparticles injected into the retina can successfully stimulate the ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Novel Sustained Release Ocular Implants PolyActiva, a clinical-stage ...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Eyedaptic, a leader in vision-enhancement solutions, today unveiled its latest breakthrough, the EYE6 with Ivy, the only wearable vision aid that both enhances ...